Resveratrol increases the bone marrow hematopoietic stem and progenitor cell capacity

• Published in: American journal of hematology Vol. 89; no. 12; pp. E235 - E238
• Main Authors: Rimmelé, Pauline, Lofek‐Czubek, Sébastien, Ghaffari, Saghi
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.12.2014
• Subjects: Animals; Antioxidants - pharmacology; Biomarkers - metabolism; Bone Marrow Cells - cytology; Bone Marrow Cells - drug effects; Bone Marrow Cells - metabolism; Cell Proliferation - drug effects; Gamma Rays; Hematology; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells - cytology; Hematopoietic Stem Cells - drug effects; Hematopoietic Stem Cells - metabolism; Injections, Intraperitoneal; Leukocyte Common Antigens - metabolism; Mice; Mice, Inbred C57BL; Stilbenes; Whole-Body Irradiation
• ISSN: 0361-8609; 1096-8652; 1096-8652
• DOI: 10.1002/ajh.23837

Resveratrol is a plant‐derived polyphenol that has shown protective effects against many disorders including, several types of cancers and other age‐associated diseases as well as blood disorders in cultured cells and/or animal models. However, whether resveratrol has any impact specifically on normal blood stem cells remains unknown. Here, we show that a 3‐week treatment of resveratrol increases the frequency and total numbers of normal bone marrow hematopoietic stem cells (HSC) without any impact on their competitive repopulation capacity. In addition, we show that resveratrol enhances the bone marrow multipotent progenitor capacity in vivo. These results have therapeutic value for disorders of hematopoietic stem and progenitor cells (HSPC) as well as for bone marrow transplantation settings. Am. J. Hematol. 89:E235–E238, 2014. © 2014 Wiley Periodicals, Inc.